Morris PG - Search Results

1

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

Morris PG, Abrey LE, Reiner AS, Wu N, Panageas KS, Seko BS, Deangelis LM, Omuro A. Morris PG, et al. Leuk Lymphoma. 2011 Oct;52(10):1891-7. doi: 10.3109/10428194.2011.585527. Epub 2011 Jun 24. Leuk Lymphoma. 2011. PMID: 21699456 Clinical Trial.

2

Therapeutic challenges in primary CNS lymphoma.

Morris PG, Abrey LE. Morris PG, et al. Lancet Neurol. 2009 Jun;8(6):581-92. doi: 10.1016/S1474-4422(09)70091-2. Lancet Neurol. 2009. PMID: 19446277 Review.

3

Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas.

Morris PG, Abrey LE. Morris PG, et al. Target Oncol. 2010 Sep;5(3):193-200. doi: 10.1007/s11523-010-0160-7. Epub 2010 Sep 16. Target Oncol. 2010. PMID: 20844972 Review.

4

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer.

Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, Hudis CA, McCormick B. Kiess AP, et al. Among authors: morris pg. Cancer. 2012 Apr 15;118(8):1982-8. doi: 10.1002/cncr.26484. Epub 2011 Sep 1. Cancer. 2012. PMID: 21887681 Free article.

5

Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.

Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR, Kris MG, Chan TA, DeAngelis LM, Omuro AM. Morris PG, et al. J Thorac Oncol. 2012 Feb;7(2):382-5. doi: 10.1097/JTO.0b013e3182398e4f. J Thorac Oncol. 2012. PMID: 22089116 Free article.

6

Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?

Morris PG. Morris PG. Anticancer Drugs. 2012 Jul;23(6):579-83. doi: 10.1097/CAD.0b013e3283528847. Anticancer Drugs. 2012. PMID: 22407251

7

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Morris PG, Murphy CG, Mallam D, Accordino M, Patil S, Howard J, Omuro A, Beal K, Seidman AD, Hudis CA, Fornier MN. Morris PG, et al. Breast J. 2012 Jul-Aug;18(4):345-50. doi: 10.1111/j.1524-4741.2012.01246.x. Epub 2012 May 21. Breast J. 2012. PMID: 22607041

8

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Morris PG, et al. J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101038 Free PMC article. Clinical Trial.

9

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Morris PG, Rota S, Cadoo K, Zamora S, Patil S, D'Andrea G, Gilewski T, Bromberg J, Dang C, Dickler M, Modi S, Seidman AD, Sklarin N, Norton L, Hudis CA, Fornier MN. Morris PG, et al. Clin Breast Cancer. 2018 Oct;18(5):387-394. doi: 10.1016/j.clbc.2018.03.010. Epub 2018 Mar 15. Clin Breast Cancer. 2018. PMID: 29680193 Free PMC article. Clinical Trial.

10

Therapeutic options for metastatic breast cancer.

Morris PG, McArthur HL, Hudis CA. Morris PG, et al. Expert Opin Pharmacother. 2009 Apr;10(6):967-81. doi: 10.1517/14656560902834961. Expert Opin Pharmacother. 2009. PMID: 19351274 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters